GC Biopharma Corp. Stock Price & Chart

KRX: 006280 · 녹십자 · KOSPI

₩128,300▼ ₩1,800 (-1.38%)at close · September 11, 2026
183,800105,900128,300Aug 20, 25Nov 26Mar 06Jun 10Sep 11, 26

GC Biopharma Corp. (녹십자, KRX: 006280) last closed at ₩128,300 on September 11, 2026, a -1.38% move on the day. Over the trailing 52 weeks the stock has traded between ₩105,900 and ₩183,800, a +0.16% change over the past year. Figures are end-of-day closing prices from the Korea Exchange.

Last close₩128,300
Day change-1.38%
52-week high₩183,800
52-week low₩105,900

Key Fundamentals

FY 2026.06
Market cap₩1.50T
P/E (PER)-320.75
P/B (PBR)1.20
EPS₩-400
BPS₩106,673
ROE-3.97%
Debt ratio112.44%
Rev. growth-3.09%

P/E, P/B and market cap are computed from the latest close; EPS, BPS, ROE and debt ratio are the most recent reported figures (FY 2026.06) from the Korea Investment & Securities Open API. Informational only, not investment advice.

Analyst Consensus

11 ratings · last Aug 20, 2026
Buy11
Hold0
Sell0
Avg. target₩185,909
Upside+44.9%
High₩200,000
Low₩160,000
BrokerageRatingTargetDate
iM SecuritiesBuy₩180,000Aug 20, 2026
Samsung SecuritiesBuy₩190,000Aug 5, 2026
Korea Investment & SecuritiesBuy₩160,000Aug 4, 2026
Daol Investment & SecuritiesBuy₩200,000Aug 3, 2026
DB SecuritiesBuy₩195,000Aug 3, 2026
Shinyoung SecuritiesBuy₩180,000Aug 3, 2026
IBK Investment & SecuritiesBuy₩190,000Jul 22, 2026
Mirae Asset SecuritiesBuy₩180,000Jul 22, 2026
Kiwoom SecuritiesBuy₩190,000Jul 21, 2026
Sangsangin Investment & SecuritiesBuy₩180,000Jul 21, 2026
KB SecuritiesBuy₩200,000May 27, 2026

Latest published rating and 12-month target price per brokerage over the past 180 days, via the Korea Investment & Securities Open API. Each house is counted once at its most recent view; averages exclude unrated notes. This summarises what analysts have published — it is not a recommendation, and not investment advice.

Technical Snapshot

as of 2026-09-11
Weak BullishAlgorithmic summary of 5 standard indicators (net score +1). Describes current technical posture only — not a buy or sell recommendation.
  • ▲ Bullish20-day MAPrice above 127,155
  • ▲ Bullish60-day MAPrice above 124,113
  • ▼ Bearish120-day MAPrice below 131,548
  • ▲ BullishMA trend (20 vs 60)Short-term above mid-term
  • · NeutralRSI (14)RSI 46 — neutral zone
  • ▼ BearishMACD (12,26,9)MACD below signal
52-week position: 29% of rangeRSI(14): 465-day volume vs 20-day: -25%

Indicators are computed mechanically from end-of-day prices. They are provided for informational purposes only, are not investment advice or a recommendation, and past performance does not indicate future results.

Reports mentioning GC Biopharma Corp.

No daily reports have covered GC Biopharma Corp. yet. New reports appear here automatically when the stock is featured.

← Back to all Korean stocks

Price history is sourced from the Korea Exchange via the Korea Investment & Securities Open API and updated after each trading session. This page is provided for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data may be delayed or contain errors — verify with an official source before trading.